KEGG   DISEASE: ホロカルボキシラーゼ合成酵素欠損症
エントリ  
H00180                                                             
名称    
ホロカルボキシラーゼ合成酵素欠損症;
複合カルボキシラーゼ欠損症
概要    
Holocarboxylase synthetase (HLCS) deficiency is an autosomal recessive disorder of biotin metabolism that results from holocarboxylase synthetase activity disruption. HLCS deficiency is also called multiple carboxylase deficiency, because deficient HLCS activity results in reduced activity of multiple carboxylases. In humans, four carboxylases are known to be biotinylated by HLCS. They are pyruvate carboxylase, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and acetyl-CoA carboxylase. Symptoms of HLCS deficiency include metabolic acidosis, a characteristic organic aciduria, lethargy, hypotonia, convulsions, and dermatitis.
カテゴリ  
先天性代謝異常症
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 05 内分泌, 栄養, 代謝の疾患
  代謝疾患
   先天性代謝異常
    5C50  アミノ酸または他の有機酸代謝の先天性異常
     H00180  ホロカルボキシラーゼ合成酵素欠損症
指定難病 [jp08407.html]
 H00180
パスウェイ 
hsa00780  Biotin metabolism
病因遺伝子 
HLCS [HSA:3141] [KO:K01942]
リンク   
ICD-11: 5C50.E0
MeSH: D028922
OMIM: 253270
文献    
  著者
Suzuki Y, Yang X, Aoki Y, Kure S, Matsubara Y
  タイトル
Mutations in the holocarboxylase synthetase gene HLCS.
  雑誌
Hum Mutat 26:285-90 (2005)
DOI:10.1002/humu.20204
文献    
  著者
Pacheco-Alvarez D, Solorzano-Vargas RS, Del Rio AL
  タイトル
Biotin in metabolism and its relationship to human disease.
  雑誌
Arch Med Res 33:439-47 (2002)
DOI:10.1016/S0188-4409(02)00399-5
LinkDB    

» English version

DBGET integrated database retrieval system